Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
COLLEGEVILLE, Pennsylvania and TARRYTOWN, New York, April 24 (ots/PRNewswire) -- - Final Decision from European Commission Expected by Mid-2008 Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), today announced that the companies have received a ...